Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - porcine circovirus type 1-type 2b chimera inactivated - unknown - porcine circovirus type 1-type 2b chimera inactivated vaccine-antigen/antibody active 0.0 - active constituent

European Union - English - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - immunologicals for suidae - pigs (for fattening) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d.active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection. onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination. duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination. in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

New Zealand - English - Ministry for Primary Industries

boehringer ingelheim animal health new zealand limited - porcine circovirus type 2 orf-2 protein - porcine circovirus type 2 orf-2 protein 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - porcine circovirus type1-type2 chimera (inactivated) - porcine circovirus type1-type2 chimera (inactivated) 0 vaccine - vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - mycoplasma hyopneumoniae; porcine circovirus type 2 orf-2 protein - mycoplasma hyopneumoniae 0 vaccine; porcine circovirus type 2 orf-2 protein 0 vaccine - vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - porcine circovirus type 2 orf2 subunit antigen - misc. vaccines or anti sera - porcine circovirus type 2 orf2 subunit antigen vaccine-viral active 7180.0 au/ml - immunotherapy

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ceva santé animale sa-nv - porcine circovirus 2 (inactivated) - emulsion for injection - porcine circovirus type 2, inactivated (pcv2) - porcine circovirus - pig

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - porcine circovirus type 1-type 2b chimera inactivated; porcine circovirus type 1-type 2a chimera inactivated; thiomersal - misc. vaccines or anti sera - porcine circovirus type 1-type 2b chimera inactivated vaccine-antigen/antibody active 1.0 rp; porcine circovirus type 1-type 2a chimera inactivated active 1.0 rp; thiomersal mercury other 0.1 mg/ml - immunotherapy

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - porcine circovirus type 1-type 2b chimera inactivated; porcine circovirus type 1-type 2a chimera inactivated; mycoplasma hyopneumoniae - inactivated antigen; thiomersal - misc. vaccines or anti sera - porcine circovirus type 1-type 2b chimera inactivated vaccine-antigen/antibody active 1.0 rp; porcine circovirus type 1-type 2a chimera inactivated active 1.0 rp; mycoplasma hyopneumoniae - inactivated antigen vaccine-general active 1.5 rp; thiomersal mercury other 0.1 mg/ml - immunotherapy

United Kingdom - English - VMD (Veterinary Medicines Directorate)

ceva animal health ltd - porcine circovirus-2 - emulsion for injection - inactivated viral vaccine - pigs